Liana K Billings MD MMSc
Diabetes, Lipid Metabolism
Research Program Director in Diabetes, Clinical Assistant in Medicine
Join to View Full Profile
9977 Woods DrSkokie, IL 60077
Phone+1 847-663-8540
Fax+1 847-663-1015
Dr. Billings is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2008- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2004 - 2007
University of Illinois College of MedicineClass of 2004
Certifications & Licensure
IL State Medical License 2007 - 2026
MA State Medical License 2008 - 2013
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
Publications & Presentations
PubMed
- Persistence with once-weekly glucagon-like peptide 1 receptor agonist therapy decreases the risk of major adverse cardiovascular events: A retrospective analysis of pa...Tyler J Dunn, Yong Zhu, Noelle N Gronroos, Lin Xie, Andrew Sargent
Diabetes Research and Clinical Practice. 2025-05-01 - Comparison of Dose Escalation Versus Switching to Tirzepatide Among People With Type 2 Diabetes Inadequately Controlled on Lower Doses of Dulaglutide : A Randomized Cl...Liana K Billings, Linsey Winne, Palash Sharma, Elisa Gomez-Valderas, K Karthik Chivukula
Annals of Internal Medicine. 2025-04-04 - Envisioning Tools to Help Classify Type 1 Diabetes and Type 2 Diabetes in New-Onset Adult Diabetes.Alessandra T Ayers, Cindy N Ho, Liana K Billings, Shivani Misra, David C Klonoff
Journal of Diabetes Science and Technology. 2025-03-28
Press Mentions
American College of Physicians, April 3-5April 15th, 2025- ACP: Switching from Dulaglutide to Tirzepatide Improves HbA1c Reduction in T2DMApril 11th, 2025
- ACP: Switching from Dulaglutide to Tirzepatide Improves HbA1c Reduction in T2DMApril 7th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
